Novo Nordisk A/S Securities Lawsuit Alert: Seeking Recovery for Investors
Novo Nordisk A/S shareholders who suffered losses may be entitled to recover under the federal securities laws. A class action lawsuit was filed against the company, alleging securities fraud between May 7, 2025, and July 28, 2025. The complaint claims that Novo Nordisk provided false and misleading statements about its growth potential, understating the impact of the personalization exception to the compounded GLP-1 exclusion and overstating the likelihood of patients switching to branded alternatives.
Key Takeaways:
- A class action securities lawsuit was filed against Novo Nordisk A/S, alleging securities fraud between May 7, 2025, and July 28, 2025.
- Defendants are accused of providing false and misleading statements about the company's growth potential, understating the impact of the personalization exception and overstating the likelihood of patients switching to branded alternatives.
- Novo Nordisk announced a lowering of its sales and profit outlook ahead of reporting its second-quarter results, attributing the guide down to "lowered growth expectations for the second half of 2025."
- Following this news, Novo Nordisk's stock price declined dramatically, falling from $69.00 to $53.94 per share in a single day.
- The lawsuit seeks to recover losses of shareholders who were adversely affected by the alleged securities fraud.
- Shareholders who suffered losses during the relevant time frame may be entitled to seek a recovery.
- Levi & Korsinsky, LLP, a nationally-recognized securities litigation firm, is experienced in representing investors in complex securities litigation.
Statistics:
- Alleged securities fraud period: May 7, 2025, to July 28, 2025
- Decline in Novo Nordisk's stock price: 21.83% in a single day
- Original stock closing price: $69.00 per share on July 28, 2025
- Stock closing price after decline: $53.94 per share on July 29, 2025
Sources:
- Newsfile Corp. (August 18, 2025) - "Novo Nordisk A/S Securities Lawsuit Alert: Seeking Recovery for Investors"
- Levi & Korsinsky, LLP (2025) - "Novo Nordisk A/S Lawsuit Submission Form 3" https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=162020&wire=5&utm_campaign=28